These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23165110

  • 1. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.
    Rossignol P, Kessler M, Zannad F.
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):59-64. PubMed ID: 23165110
    [Abstract] [Full Text] [Related]

  • 2. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
    Rossignol P, Cridlig J, Lehert P, Kessler M, Zannad F.
    Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936
    [Abstract] [Full Text] [Related]

  • 3. Visit-to-visit blood pressure variability, silent cerebral injury, and risk of stroke.
    Nagai M, Kario K.
    Am J Hypertens; 2013 Dec; 26(12):1369-76. PubMed ID: 24080990
    [Abstract] [Full Text] [Related]

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 5. Treatment of hypertension based on measurement of blood pressure variability: lessons from animal studies.
    Su DF.
    Curr Opin Cardiol; 2006 Sep; 21(5):486-91. PubMed ID: 16900013
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.
    Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E, Office versus Ambulatory Pressure Study Investigators.
    N Engl J Med; 2003 Jun 12; 348(24):2407-15. PubMed ID: 12802026
    [Abstract] [Full Text] [Related]

  • 7. Blood pressure variability and cardiovascular risk in treated hypertensive patients.
    Pierdomenico SD, Lapenna D, Di Tommaso R, Di Carlo S, Esposito AL, Di Mascio R, Ballone E, Cuccurullo F, Mezzetti A.
    Am J Hypertens; 2006 Oct 12; 19(10):991-7. PubMed ID: 17027816
    [Abstract] [Full Text] [Related]

  • 8. [Hypertension and renal disease].
    Kamper AL, Pedersen EB, Strandgaard S.
    Ugeskr Laeger; 2009 Jun 15; 171(25):2109-13. PubMed ID: 19671393
    [Abstract] [Full Text] [Related]

  • 9. [High prognostic significance of blood pressure variability in consecutive checks].
    van Montfrans GA.
    Ned Tijdschr Geneeskd; 2010 Jun 15; 154():A2670. PubMed ID: 20977807
    [Abstract] [Full Text] [Related]

  • 10. [Variability in blood pressure and arterial hypertension].
    Widimský J.
    Vnitr Lek; 2011 Mar 15; 57(3):320-4. PubMed ID: 21495416
    [Abstract] [Full Text] [Related]

  • 11. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR, Zappe D, Orloski LA, Sowers JR.
    J Hum Hypertens; 2011 Apr 15; 25(4):211-7. PubMed ID: 20596060
    [Abstract] [Full Text] [Related]

  • 12. Visit-to-visit variability of blood pressure: current knowledge and future research directions.
    Muntner P, Levitan EB.
    Blood Press Monit; 2013 Aug 15; 18(4):232-8. PubMed ID: 23676615
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure variability and organ damage.
    Mancia G, Frattola A, Parati G, Santucciu C, Ulian L.
    J Cardiovasc Pharmacol; 1994 Aug 15; 24 Suppl A():S6-11. PubMed ID: 7603077
    [Abstract] [Full Text] [Related]

  • 14. Blood pressure variability: clinical implications and effects of antihypertensive treatment.
    Parati G, Ravogli A, Frattola A, Groppelli A, Ulian L, Santucciu C, Mancia G.
    J Hypertens Suppl; 1994 Jul 15; 12(5):S35-40. PubMed ID: 7965285
    [Abstract] [Full Text] [Related]

  • 15. Recognition and management of masked hypertension: a review and novel approach.
    Yano Y, Bakris GL.
    J Am Soc Hypertens; 2013 Jul 15; 7(3):244-52. PubMed ID: 23523411
    [Abstract] [Full Text] [Related]

  • 16. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
    García-Donaire JA, Segura J, Cerezo C, Ruilope LM.
    Blood Press; 2011 Dec 15; 20(6):322-34. PubMed ID: 21936729
    [Abstract] [Full Text] [Related]

  • 17. Influence of renin angiotensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients.
    Kawai T, Ohishi M, Onishi M, Takeya Y, Ito N, Kato N, Yamamoto K, Kamide K, Rakugi H.
    Am J Hypertens; 2012 Dec 15; 25(12):1249-55. PubMed ID: 22932704
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 1998 Jan 15; 16(1):S53-8. PubMed ID: 9534098
    [Abstract] [Full Text] [Related]

  • 19. Should we shift toward higher blood pressure targets in patients with chronic kidney disease?
    Gentile G, Strippoli GF.
    J Nephrol; 2011 Jan 15; 24(6):673-85. PubMed ID: 22058026
    [Abstract] [Full Text] [Related]

  • 20. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G, Seravalle G, Grassi G.
    Ann Ital Med Int; 1997 Jan 15; 12(4):217-22. PubMed ID: 9773576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.